Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
135,9 EUR | -0,69 % |
|
-1,10 % | -3,46 % |
02/07 | Momentum Picks T3 2024: 5 valores para el verano | ![]() |
02/07 | Johnson & Johnson afirma que los análisis provisionales del estudio de su terapia contra el cáncer de sangre son prometedores | MT |
Publs. oficiales
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Shareholders meeting voting results | CO | |
SEC Filing 8K | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 13G | CO | |
Proxy Statments | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |